KL
KCK Ltd Portfolio holdings
AUM
$18.3M
This Quarter Return
+77.48%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$70.4M
AUM Growth
+$70.4M
(+10%)
Cap. Flow
-$14.5K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Sight Sciences
SGHT
|
$14.5K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neuropace
NPCE
$303M
| $54.7M | 77.7% |
5,621,111
| – | – |
|
|
2
Sight Sciences
SGHT
$213M
| $15.7M | 22.25% |
4,646,866
-4,299
| -0.1% | -$14.5K |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $34K | 0.05% |
22,341
| – | – |
|